1988
DOI: 10.1002/chin.198841217
|View full text |Cite
|
Sign up to set email alerts
|

ChemInform Abstract: Aminophthalazinone Derivatives. Part 12. Methods for the Synthesis of Imidazo(2,1‐a)phthalazine and Pyrimido(2,1‐a)phthalazine Ring Systems. Part 2. Thermal Transformation of Acyloxyalkylaminopthalazinones.

Abstract: O‐acetyl derivatives of the phthalazinones (I) and (VII) undergo proton‐catalyzed ring‐closure reactions in the melt to give the title ring systems (III) and (VIII), respectively.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2004
2004

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Our strategy began with the screening of literature compounds, known to be benzodiazepine site GABA-A ligands, and the Merck sample collection for GABA-A α2/α3 subtype selective leads. The 2,3-dihydrophthalazine-1,4-dione 5 (Table ) was identified as a weakly active α2/α3 binding selective compound, but initial optimization studies involving independent deletion and replacement of hydrogen-bonding and hydrophobic groups gave only inactive compounds. We were intrigued by the similarity of 5 to the known GABA-A ligand 6 (Table ), which has been reported to show some dissociation of anxiolysis and sedation, and thus, we identified the molecule 7 as one potential target along with other hybrid molecules.…”
Section: Lead Identificationmentioning
confidence: 99%
“…Our strategy began with the screening of literature compounds, known to be benzodiazepine site GABA-A ligands, and the Merck sample collection for GABA-A α2/α3 subtype selective leads. The 2,3-dihydrophthalazine-1,4-dione 5 (Table ) was identified as a weakly active α2/α3 binding selective compound, but initial optimization studies involving independent deletion and replacement of hydrogen-bonding and hydrophobic groups gave only inactive compounds. We were intrigued by the similarity of 5 to the known GABA-A ligand 6 (Table ), which has been reported to show some dissociation of anxiolysis and sedation, and thus, we identified the molecule 7 as one potential target along with other hybrid molecules.…”
Section: Lead Identificationmentioning
confidence: 99%